3Wright TC,Cox Jr JT,Massad S,et al.2001 Consensus guidelines for the managerment of women with cervical intraepithelial neoplasia[J].AJOG,2003,189:295-304.
4Wright TC,Cox JrJT,Massad S,et al.2001 Consensus guidelines for the management of women with cervical cytological abnormalities[J].JAMA,2002,287:2120-2129.
5Solomon D,Nayar R.The Bethesda system for reporting cervical cytology[M].2nd ed.New York:Springer-Verlag,2004:67-87.
6Ferris DG,Cox TJ.Modern colposcopy:textbook and atlas[M].2nd ed.USA:Kendal/hunt Publishing Company,2004:144-483.
7Kuhn L,Denny L,Pollack A,et al.Human papillomavirus DNA testing for cervical cancer screening in low-resource settings[J].Natl Cancer Inst,2000,92(2):818-822.
8Tsai HJ,Wu CH,Lai HL,et al.Association between quantitative high-risk human papillomavirus DNA load and cervical intraepithelial neoplasm risk[J].Cancer Epidemiol Biomarkers Prev,2005,14(11Pt1):2544-2549.
9Tsuda H,Hashiguchi Y,Nishimura S,et al.Relationship between HPV typing and abnormality of G1 cell cycle regulators in cervical neoplasm[J].Gynecol Oncol,2003 (2),91:476-485.
10Bulk S,Berkhof J,Bulkmans NW,et al.Preferential risk of HPV16 for squamous cell carcinoma and of HPV 18 for adenocarcinoma of the cervix compared to women with normal cytology in the Netherlans[J].Br J Cancer,2006,94 (1):171-175.
